Caplight Directory>Companies>Mediphage Bioceuticals-preview>Mediphage


Mediphage Bioceuticals

Mediphage Bioceuticals

Private
Toronto, OntarioN/Ahttps://www.mediphage.ca/

Last Round

Grant

Jan 6, 2026

Total Funding Raised

$3.41M

Momentum Score

50 /100

Company Overview

Mediphage Bioceuticals is a biotechnology company that develops a non-viral gene therapy platform called ministring DNA (msDNA) for applications in gene therapy, cell engineering, and DNA vaccines.

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mediphage Bioceuticals Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Mediphage Bioceuticals Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantJan 6, 2026
SeedFeb 7, 2024
SeedDec 16, 2021
GrantJun 15, 2020
SeedJul 15, 2019
Accelerator
Apr 26, 2018
View all Funding Rounds

Key People

Founding team and executive leadership

Nafiseh Nafissi

Chief Technology Officer

Executive Team

Mediphage Bioceuticals Investors

Notable investors and investment history

InvestorRounds
National Research Council Canada Industrial Research Assistance ProgramGrant
Innovate UKGrant
CCRM Enterprises Inc.Seed
Riverine VenturesSeed
Illumina AcceleratorAccelerator
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors increased 75% MoM.

  • Jan 27, 2026

    Monthly visitors grew 1820% MoM, from 35 to 672.

View all signals

Mediphage Bioceuticals Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Mediphage Bioceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mediphage Bioceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto, Ontario
Employee Range6
Year Founded2016
Last FundingJan 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.